Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
3,750 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
850 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
400 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
2,500 |
CARE_SITE |
Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
11 |
CARE_SITE |
Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
5 |
CARE_SITE |
Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
2 |
CARE_SITE |
Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole |
2015 |
4 |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
14 |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
5 |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
3 |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
6 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
600 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
330 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
120 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
150 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
105 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
35 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
30 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
40 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
595 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
315 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
120 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
160 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2015 |
700 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2015 |
350 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2015 |
150 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2015 |
200 |
LAB_CAP |
By site support type: Technical Assistance-only (TA) |
2015 |
4 |
LAB_CAP |
By site support type: Technical Assistance-only (TA) |
2015 |
4 |
LAB_CAP |
By site support type: Technical Assistance-only (TA) |
2015 |
5 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
13 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
4 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
4 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
5 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
4 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
4 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
5 |
QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
14 |
QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
5 |
QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
3 |
QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
6 |
QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
14 |
QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
5 |
QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
3 |
QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
6 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
14 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
6 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
14 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
4 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: Key Populations Prevention Technical Assistance-only (TA) |
2015 |
14 |
SITE_SUPP |
By program area/support type: Key Populations Prevention Technical Assistance-only (TA) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Key Populations Prevention Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: Key Populations Prevention Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: Lab Technical Assistance-only (TA) |
2015 |
13 |
SITE_SUPP |
By program area/support type: Lab Technical Assistance-only (TA) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Lab Technical Assistance-only (TA) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Lab Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
14 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
5 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
6 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
31 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
10 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
9 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
12 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
2,210 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
710 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
250 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
1,250 |